| DAA2020 |
Reduction in renal function |
Physiological |
kidney |
Human |
— |
— |
|
| DAA886 |
Renal arteriosclerosis |
Pathological |
renal vasculature |
Human |
— |
— |
|
| DAA885 |
Renal blood flow declines |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA640 |
Renal failure |
Pathological |
kidney |
Human |
— |
SeriesMorbidity |
|
| DAA897 |
Response to antidiuretic hormone decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA276 |
Rh family, C glycoprotein |
Molecular |
kidney |
Human |
RHCG |
16.0% Decrease Gene Expression Level |
|
| DAA282 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
Molecular |
kidney |
Human |
SERPINA5 |
11.0% Decrease Gene Expression Level |
|
| DAA902 |
specific activities of enzymes are reduced |
Molecular |
kidney |
Human |
— |
— |
|
| DAA898 |
Sodium conservation decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA268 |
solute carrier family 12 (sodium/chloride transporters), member 3 |
Molecular |
kidney |
Human |
SLC12A3 |
16.0% Decrease Gene Expression Level |
|
| DAA286 |
StAR-related lipid transfer (START) domain containing 8 |
Molecular |
kidney |
Human |
STARD8 |
14.0% Decrease Gene Expression Level |
|
| DAA901 |
telomere shortening |
Molecular |
kidney |
Human |
— |
— |
|
| DAA904 |
Transport maximum for glucose declines |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA277 |
tyrosinase-related protein 1 |
Molecular |
kidney |
Human |
TYRP1 |
21.0% Decrease Gene Expression Level |
|
| DAA900 |
Urine concentrating capacity decreases |
Physiological |
renal tubule |
Human |
— |
— |
|
| DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA1498 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
Molecular |
kidney |
Mouse |
Hmgcs1 |
4.0% Decrease Gene Expression Level |
|
| DAA1489 |
acyl-CoA synthetase medium-chain family member 2 |
Molecular |
kidney |
Mouse |
Acsm2 |
5.0% Decrease Gene Expression Level |
|
| DAA1485 |
acylphosphatase 2, muscle type |
Molecular |
kidney |
Mouse |
Acyp2 |
7.0% Decrease Gene Expression Level |
|
| DAA1475 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
Molecular |
kidney |
Mouse |
Adamts1 |
7.0% Increase Gene Expression Level |
|
| DAA1467 |
annexin A2 |
Molecular |
kidney |
Mouse |
Anxa2 |
8.0% Increase Gene Expression Level |
|
| DAA1464 |
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 |
Molecular |
kidney |
Mouse |
Atp5f1 |
5.0% Decrease Gene Expression Level |
|
| DAA1477 |
biglycan |
Molecular |
kidney |
Mouse |
Bgn |
10.0% Increase Gene Expression Level |
|
| DAA1458 |
brevican |
Molecular |
kidney |
Mouse |
Bcan |
6.0% Decrease Gene Expression Level |
|